USFDA to import cancer drug from Sun Pharma

Image
Press Trust Of India New Delhi
Last Updated : Jan 20 2013 | 3:02 AM IST

US health regulator the United States Food and Drug Administration (USFDA) has said it will import cancer drug Lipodox from India’s Sun Pharma to meet the shortage of another similar medicine Doxil.

In response to the critical shortage of the cancer drug Doxil and rapidly declining supplies of methotrexate, the USFDA took proactive steps needed to increase available supply for patients in the US.

“For Doxil, there will be temporary importation of a replacement drug, Lipodox which is expected to end the shortage and fully meet patient needs in the coming weeks,” USFDA said on its website.

More From This Section

First Published: Feb 24 2012 | 1:35 AM IST

Next Story